Filing Details

Accession Number:
0001062993-23-007574
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-23 19:31:37
Reporting Period:
2023-03-21
Accepted Time:
2023-03-23 19:31:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1850119 Century Therapeutics Inc. IPSC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684015 Luis Borges 3675 Market Street
Philadelphia PA 19104
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-21 63,616 $1.03 107,366 No 4 M Direct
Common Stock Disposition 2023-03-21 63,616 $3.77 43,750 No 4 S Direct
Common Stock Acquisiton 2023-03-22 65,698 $1.03 109,448 No 4 M Direct
Common Stock Disposition 2023-03-22 65,698 $3.72 43,750 No 4 S Direct
Common Stock Acquisiton 2023-03-23 220,930 $1.03 264,680 No 4 M Direct
Common Stock Disposition 2023-03-23 15,597 $3.55 249,083 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-03-21 63,616 $0.00 63,616 $1.03
Common Stock Stock Option (right to buy) Disposition 2023-03-22 65,698 $0.00 65,698 $1.03
Common Stock Stock Option (right to buy) Disposition 2023-03-23 220,930 $0.00 220,930 $1.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
294,080 2029-07-17 No 4 M Direct
228,382 2029-07-17 No 4 M Direct
7,452 2029-07-17 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.935, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.57 to $3.79, inclusive.
  3. The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.